Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The "lung system" refers to the respiratory organs and tissues involved in breathing and gas exchange in the body. It is not a molecular or therapeutic target, but rather a complex system composed of multiple cell types, extracellular matrices, and anatomical structures. In the context of disease, particularly lung cancer, molecular targets are more specifically individual genes (e.g., EGFR, ALK, KRAS), proteins, or receptors within lung tissues[4][5][2]. The WHO classification of lung cancer, for example, organizes neoplasms by cell and molecular subtype (e.g., non-small cell lung cancer, small cell lung cancer) rather than considering the "lung system" as a molecular target[5]. No specific abbreviation, mechanism of action, or interacting drugs exist for the "lung system" as a molecular target. Where relevant, research and treatment focus on defined molecular entities within lung tissues, such as growth factor receptors or oncogenes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lung system.